The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
50% of HIV-positive adults in the US are age 50 or older and hepatitis C is now a curable ill- ness due to treatment advances. This session emphasizes basics of antiretroviral therapy and new hepatitis C treatments.
Contact hours available until 3/25/19.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee: No planning committee member discloses a potential or actual conflict of interest.
Speakers: There are no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or corporate sponsorship was received.
Accreditation Statement: This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and GAPNA.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Learning Outcome: After completing this learning activity, the learner will be able to understand considerations for initiating and managing antitretroviral therapy regimens and understand new treatment options for hepatitis C and special considerations for both for older patients.